We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
hENT-1 Expression and Localization Predict Outcome After Adjuvant Gemcitabine in Resected Cholangiocarcinoma Patients.
- Authors
Meijer, Laura L.; Puik, Jisce R.; Peters, Godefridus J.; Kazemier, Geert; Giovannetti, Elisa
- Abstract
In this letter to the editor, the authors discuss the use of human equilibrative nucleoside transporter 1 (hENT‐1) as a biomarker in patients with cholangiocarcinoma. They encourage standardization of techniques to evaluation expression of proteins such as hENT‐1 and suggest additional studies investigating the active metabolites of gemcitabine, the use of liquid biopsies, and improved statistical methods.
- Subjects
ANTIMETABOLITES; BIOPSY; IMMUNOHISTOCHEMISTRY; METASTASIS; CHOLANGIOCARCINOMA
- Publication
Oncologist, 2016, Vol 21, Issue 12, pe4
- ISSN
1083-7159
- Publication type
Letter to the Editor
- DOI
10.1634/theoncologist.2016-0262